JPRN-UMIN000010934已完成2 期
A phase II study of surgical treatment for non-small cell lung cancer patients with distant oligometastases - A phase II study of surgical treatment for non-small cell lung cancer patients with distant oligometastases
Japanese Northern East Area Thoracic Surgery Study Group (JNETS)0 个研究点目标入组 55 人开始时间: 2013年6月12日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Preoperative therapy for primary lung cancer 2)c/pN2 3)Direct extrapulmonary extension 4)With bone metastasis 5)With bilateral adrenal metastases 6)With bilateral renal metastases 7)With active double cancers within 5 years 8)With local recurrence (in a case having metachronous metastasis) 9)Metastasis more than 5 years after operation of primary lung cancer (in a case having metachronous metastasis) 10)Clinically significant complications
研究者
相似试验
招募中
2 期
Phase II clinical trial of surgical intervention following chemotherapy for synchronous and metachronous liver metastasis from gastric cancer.Patients with synchronous or metachronous liver metastasis from gastric cancerJPRN-UMIN000011445Department of Surgery, Osaka University Graduate School of Medicine50
招募中
2 期
Phase II clinical trial of surgical intervention following chemotherapy for synchronous and metachronous liver metastasis from gastric cancer.(HiSCO 06)Patients with synchronous or metachronous liver metastasis from gastric cancerJPRN-UMIN000024004Hiroshima Surgical Study group of Clinical Oncology (HiSCO)30
尚未招募
不适用
Prospective investigation for surgical therapy of non-reconstructable rotator cuff lesionsM75.1Rotator cuff syndromeDRKS00022942Vivantes Humboldt-Klinikum BerlinDirektor Department für Bewegungschirurgie50
进行中（未招募）
不适用
Phase II study on curative resectability of not optimally resectable liver and/or lung metastases from colorectal carcinoma (CRC) under intensified chemotherapy (FLOFOXIRI/Bevacizumab). - APRIORIEUCTR2007-004535-33-DEniversitätsklinikum Heidelberg
进行中（未招募）
不适用
A phase II study for the treatment of patients with splenic marginal lymphoma with the combination of Cyclophosfamide, Vincristine, Liposomal Doxorubicin, Predinisone and RituximabTreatment of patients with newly diagnosed splenic marginal non Hodgkin lymphomaMedDRA version: 9.1Level: LLTClassification code 10062113Term: Splenic marginal zone lymphomaEUCTR2005-000693-45-ITG.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI